The aim of this study was to evaluate the extent of endogenous carbon monoxide production in subjects with ineffective erythropoiesis. Carboxyhaemoglobin concentrations were measured in eight transfused and eight non transfused thalassemic patients. Measurements were made on venous blood collected under controlled conditions and were corrected by simultaneous measurement of HbF levels. Nontransfused thalassaemic patients with abnormal erythropoiesis were found to have elevated levels of carboxyhaemoglobin, significantly higher than those found in transfused subjects, as well as decreased cardiac performance. It is important to consider carboxyhaemoglobin levels in planning transfusion programmes.
SUMMARY. The aim of this study was to evaluate the extent of endogenous carbon monoxide production in subjects with ineffective erythropoiesis. Carboxyhaemoglobin concentrations were measured in eight transfused and eight non transfused thalassemic patients. Measurements were made on venous blood collected under controlled conditions and were corrected by simultaneous measurement of HbF levels. Nontransfused thalassaemic patients with abnormal erythropoiesis were found to have elevated levels of carboxyhaemoglobin, significantly higher than those found in transfused subjects, as well as decreased cardiac performance. It is important to consider carboxyhaemoglobin levels in planning transfusion programmes.
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Carbon monoxide (CO) is a widespread environmental pollutant and an endogenous product of haem catabolism. 1 CO binds reversibly to haemoglobin to form carboxyhaemoglobulin (HbCO), a stable complex that carries it away from tissues, preventing direct damage.' However, CO is indirectly toxic because it lessens the amount of haemoglobin able to carry oxygen and increases whole blood oxygen affinity, thus lowering oxygen availability to tissues.J Exposure to exogenous CO and its consequences is a wellstudied phenomenon; the extent and importance of endogenous CO production has not yet received full consideration. Under normal conditions endogenous CO production gives rise to HbCO concentrations of 0·4-0' 70/0 of total Hb.
Evidence indicates that in patients with ineffective erythropoiesis endogenous production of CO is exaggerated because of the degradation of immature red cells within the marrow. 4 It is common practice to give homozygous {jthalassaemic patients regular blood transfusions in order to maintain haemoglobin levels above 10 g/dL; in this way erythropoiesis should be depressed. In contrast, patients affected by Correspondence: Dr A Fiorillo, I Divisione di Pediatria, II Facolta di Medicina, Via S. Pansini 5, 80131 Napoli, Italy. thalassaemia intermedia spontaneously maintain haemoglobin levels between 7 and 9 g/dL; they are not as a rule subjected to transfusional therapy. In these patients abnormal erythropoiesis is to be expected with a consequent increase in endogenous CO production.
We have assessed the HbCO concentration in nontransfused thalassaemic children in order to elucidate the extent of endogenous CO production in these patients who are presumably subjected to ineffective erythropoiesis. For comparison, transfused thalassaemic patients have also been tested, in which an increased CO production deriving from an exaggerated catabolism of circulating red cells should be expected.
PATIENTS, METHODS AND RESULTS
We measured the HbCO levels in the venous blood of 16 patients affected by homozygous {jthalassaemia diagnosed on clinical, haematological and genetic criteria. The first group of eight patients (three boys, five girls) were receiving regular blood transfusions in order to maintain haemoglobin levels above 10 g/dL; their age at time of test varied between 4 years and 13 years 3 months (mean age 9 years 9 months). All patients in this group had been diagnosed and started the transfusion programme in their first year of life; they were tested before and 2 hand 8 h after a transfusion of packed red cells. In three patients the above determinations were repeated 7, 14 and 21 days after the transfusion. The second group of children was represented by eight subjects (six boys, two girls) affected by thalassaemia intermedia and spontaneously maintaining haemoglobin values between 7·9 and 9· 8 gldL. Their ages were between 15 months and 17 years (mean age 7 years 10 months). All determinations were done on heparinized blood collected by venopuncture, in the same hospital room where the patients had rested overnight.
HbCO concentrations were measured using a CO-oximeter model 282 (Instrumentation Laboratory, Lexington, MA, USA). HbCO values were corrected by simultaneous measurement of HbF levels according to Cornelissen et al.S
All regularly transfused patients showed low HbCO concentrations between O' 3 and 3· 4010 (mean value 1· 68; Fig. 1) . The three patients sequentially tested showed a slight increase of the HbCO concentration, up to 2·5%, at the 14th day after the transfusion; values returning toward the normal range at the 21st day (Fig. 2) . By contrast, patients affected by thalassaemia intermedia 21 Days Transfusiañ
Acute CO poisoning is a well-known and easily recognizable entity. At a level of 10% to 30% exertional dyspnoea and headache are manifest. Repeated exposure to low concentrations of CO is an insidious condition that can produce less recognizable symptoms. Headache, fatigue, difficulty in thinking, dizziness and deterioration DISCUSSION showed significantly higher HbCO values, ranging from 1·26% to 8% (mean value 4· 74% (Fig. I) . The difference is statistically significant (Wilcoxon test; P=0·OO(31). Data from an age matched control group of nine subjects (ranging in age from 3 years to 13 years 6 months, mean age 7 years 2 months), tested under identical conditions, are also shown in Fig. I .
The cardiological performance of our thalassaemic patients is regularly checked by biannual echocardiographic observations. Dimensions of the left ventricle in systole (LVSD) and in diastole (LVDD) are taken according to the recommendations of the American Society of Bchocardiography;" the shortening fraction of the left ventricle is also calculated (SF = (LVDD-LVSD/LVDD)X 1(0). Seven of the 16 patients reported in the present study received an echocardiographic evaluation of their cardiological performance, no more than 3 months from the day when they were tested for HbCO concentration. As shown in Table I , patients 1,2 and 3, belonging to the group of nontransfused subjects and sharing elevated HbCO levels, had decreased shortening fraction. In contrast, patients with low HbCO concentrations showed normal echocardiographic findings. of performance at school are reported in these subjects." In our non transfused thalassaemic patients we found elevated levels of HbCO, up to 10 times higher than those found in transfused subjects. In particular, two of them showed HbCO concentrations very close to the threshold level at which clinical signs become evident (HbCO concentrations of 8% and 7· 8%; Fig. I) , although in fact they did not show any evident clinical symptoms or signs of CO poisoning. However, one of them (case 1 in Table I) , together with two other nontransfused thalassaemic patients, with lower HbCO levels, was evaluated by the measurement of shortening fraction and found to have a decreased cardiac performance. The fact that shortening fraction was in the normal range for our transfused patients suggests that these changes were a consequence of chronic anoxia due to the elevated HbCO levels and not of the thalassaemia itself.
This observation seems to confirm the hypothesis that the catabolism of haem or haem precursors in the marrow constitutes a major source of endogenous CO in states of ineffective erythropoiesis. This phenomenon causes much higher concentrations of HbCO than those derived from circulating haem catabolism in patients with haemolytic anaemia in which erythropoiesis is depressed by transfusional therapy.
Therefore patients with abnormal erythropoiesis may be at risk of chronic CO poisoning. Moreover, in nontransfused thalassaernic patients the effect of HbCO on the oxygen dissociation curve" is combined with a low oxygen availability to tissues deriving from low haemoglobin levels, and for this reason an increased risk of the above mentioned complications would be expected. We recommend that HbCO levels should be measured in such patients and taken into account in planning therapeutic programmes.
